Algorae Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Algorae Pharmaceuticals has a total shareholder equity of A$3.0M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$3.2M and A$178.4K respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$3.11m |
| Equity | AU$3.01m |
| Total liabilities | AU$178.45k |
| Total assets | AU$3.19m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 1AI's short term assets (A$3.2M) exceed its short term liabilities (A$178.4K).
Long Term Liabilities: 1AI has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 1AI is debt free.
Reducing Debt: 1AI has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1AI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 1AI has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 9.8% each year.